Replies to post #405492 on NorthWest Biotherapeutics Inc (NWBO)

[kabunushi]

Please show the corresponding expenses and payments to Advent by NWBO. Without that cross-reference your info is more or less meaningless. It certainly proves nothing about Advents business with NWBO. The fact is we have full financial statements from NWBO so it blows my mind you are making wild guesses without even looking at that very detailed data.

[biosectinvestor]

Your data is unclear, from where exactly is all of it derived? Not sure how you provide the numbers for Cognate in pounds. It was a private US company, and then these are monies passing through to other persons and companies. Contracts for a CDMO are OBLIGATIONS, and more so when they do not have their own facility. Lots of money passes through and does not stay. In this case they have no assets, no factory, no machinery. Yes, they had a lease in London, but again, that is an obligation ultimately, and they only make money when they net money after all the expenses. What scale of production could they possibly have had in the London facility? Whose production?

Their assets are people they have an obligation to pay.

I don’t believe they had enough people on payroll nor that the volume of payments would be for the production of DCVax as you’ve suggested here. Are you claiming that they are so highly valued because of production at the London facility that they and NWBO did not own? Explain exwctly how it is that a company that retains so little in terms of equity and where virtually all the funds pass immediately back out to third-parties is worth a huge amount. It would make no sense to value such a service firm by its revenues.

I just do not see it. I think you’re saying anything to justify a bogus case.